10-110812297-C-T
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong
The NM_001134363.3(RBM20):c.1900C>T(p.Arg634Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R634Q) has been classified as Pathogenic.
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.1900C>T | p.Arg634Trp | missense_variant | 9/14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.1735C>T | p.Arg579Trp | missense_variant | 9/14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.1516C>T | p.Arg506Trp | missense_variant | 9/14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.1516C>T | p.Arg506Trp | missense_variant | 9/14 | XP_047281072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM20 | ENST00000369519.4 | c.1900C>T | p.Arg634Trp | missense_variant | 9/14 | 1 | NM_001134363.3 | ENSP00000358532 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1394920Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 687254
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2023 | Reported in multiple unrelated individuals with DCM or left ventricular dysfunction (Li et al, 2010; Refaat et al., 2012; Hazebroek et al., 2018; van Waning et al., 2018; van den Hoogenhof et al., 2018; Pantou et al., 2018; Horvat et al., 2019; Das and Seth, 2021; Liatakis et al., 2021); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30847666, 32880476, 33671899, 34021826, 34322310, 30557877, 22004663, 29892087, 20590677, 29540472, 29447731, 29650543, 32674065, 35653365) - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 10, 2022 | PP1_strong, PM1, PM2_supporting, PM5, PS4_moderate - |
Dilated cardiomyopathy 1DD Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 634 of the RBM20 protein (p.Arg634Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with dilated cardiomyopathy (DCM) (PMID: 20590677, 29447731, 29540472, 29895960, 30557877). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 411653). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RBM20 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects RBM20 function (PMID: 29895960). This variant disrupts the p.Arg634 amino acid residue in RBM20. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19712804, 20590677, 22466703, 29029073). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 05, 2024 | The p.R634W pathogenic mutation (also known as c.1900C>T), located in coding exon 9 of the RBM20 gene, results from a C to T substitution at nucleotide position 1900. The arginine at codon 634 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration is located in the highly conserved RSRSP stretch that contains the majority of pathogenic RBM20 mutations (Watanabe T et al. Front Mol Biosci, 2018;5:105). This alteration has been detected in multiple individuals with dilated cardiomyopathy (DCM) and has been reported to segregate with disease in several families (Li D et al. Clin Transl Sci, 2010 Jun;3:90-7; Hazebroek MR et al. Circ Heart Fail, 2018 03;11:e004682; Pantou MP et al. Cardiology, 2018 Dec;141:150-155; van den Hoogenhof MMG et al. Circulation, 2018 09;138:1330-1342; Horvat C et al. Genet. Med., 2019 01;21:133-143; Yao JV et al, 2020 Aug;6:499-502). Functional studies suggest that R634W disrupts the phosphorylation of the RSRSP stretch, causes mislocalization, and leads to diminished splicing regulation activity (Murayama R et al. Sci Rep, 2018 06;8:8970). Another alteration at the same codon, p.R634Q (c.1901G>A), has been detected in individuals with DCM (Li D et al. Clin. Trans. Sci. 2010 Jun;3(3):90-7; Brauch KM et al. J. Am. Coll. Cardiol. 2009 Sep;54(10):930-42). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at